Identifying nursing home residents at high risk for preventable adverse drug events: modifying a tool for use in the Fleetwood Phase III Study.
To modify and test a screening tool for identification of nursing home residents at high risk for preventable adverse drug events. Retrospective descriptive study. 30 skilled nursing facilities in North Carolina receiving pharmacy benefits from one provider. All patients residing in these homes. Modification of high-risk screening tool for use in the Fleetwood Phase III Study. Proportion of residents who trigger high-risk screen for preventable adverse drug events. The median proportion of residents triggered was one-third; in some facilities only about 15% of the residents were deemed high-risk while in others the estimate was as high as 48%. The most likely medication classes triggering a chart review was use of seven or more medications, with one medication being an antidepressant. The modified high-risk screening tool proved to be practical and clinically relevant. It will be used to maximize pharmacists' time and skills in preventing adverse drug events in nursing home residents in the Fleetwood Phase III evaluation.